Effect of streptozotocin on the glycemic and lipid profiles and oxidative stress in hamsters;Efeito da estreptozotocina sobre os perfis glicêmico e lipídico e o estresse oxidativo em hamsters

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 1, 2011, Pages 46-53

  Silva, Maísa ^a   de Lima, Wanderson Geraldo ^a   Pedrosa, Marcelo Eustáquio Silva Lucia ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Antioxidants; Hamsters; Oxidative stress; Streptozotocin

Indexed keywords

STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HAMSTER; LIPID PEROXIDATION; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RANDOMIZATION; SYRIAN HAMSTER;

ANIMALS; BLOOD GLUCOSE; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; LIPID PEROXIDATION; MALE; MESOCRICETUS; OXIDATIVE STRESS; RANDOM ALLOCATION; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

EID: 79954493094     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302011000100006     Document Type: Article

References (39)

1. Conget I. [Diagnosis, classification and cathogenesis of diabetes mellitus]. Rev Esp Cardiol. 2002;55(5):528-535.
2. Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care. 2000;23(3):381-383.
3. Ceriello A. Oxidative stress and glycemic regulation. Metabolism. 2000;49(2 Suppl 1):27-29.
4. Reis JS, Veloso CA, Mattos RT, Purish S, Nogueira-Machado JA. [Oxidative stress: a review on metabolic signaling in type 1 diabetes]. Arq Bras Endocrinol Metabol. 2008;52(7):1096-1105.
5. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40(4):405-412.
6. Najib S, Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. J Mol Endocrinol. 2001;27(1):85-91.
7. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes. 1998;47(10):1562-1569.
8. Bertelsen M, Anggard EE, Carrier MJ. Oxidative stress impairs insulin internalization in endothelial cells in vitro. Diabetologia. 2001;44(5):605-613.
9. Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med. 2005;22(4):359-370.
10. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia. 2000;43(12):1528-1533.
11. Bennett RA, Pegg AE. Alkylation of DNA in rat tissues following administration of streptozotocin. Cancer Res. 1981;41(7):2786-2790.
12. Bolzan AD, Bianchi MS. Genotoxicity of streptozotocin. Mutat Res. 2002;512(2-3):121-134.
13. Takasu N, Komiya I, Asawa T, Nagasawa Y, Yamada T. Streptozocinand alloxan-induced H2O2 generation and DNA fragmentation in pancreatic islets. H2O2 as mediator for DNA fragmentation. Diabetes. 1991;40(9):1141-1145.
14. Phares CK. Streptozotocin-induced diabetes in Syrian hamsters: new model of diabetes mellitus. Experientia. 1980; 36(6):681-682.
15. Rauscher FM, Sanders RA, Watkins JB, III. Effects of new antioxidant compounds PNU-104067F and PNU-74389G on antioxidant defense in normal and diabetic rats. J Biochem Mol Toxicol. 2000;14(4):189-194.
16. Colégio Brasileiro de Experimentação Animal. Princípios éticos na experimentação animal do Colégio Brasileiro de Experimentação Animal. São Paulo: COBEA, 1991.
17. Simionescu M, Popov D, Sima A, Hasu M, Costache G, Faitar S, et al. Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamster. Am J Pathol. 1996;148(3):997-1014.
18. Beltowski J, Wojcicka G, Jamroz A. Differential effect of 3-hydroxy-3- -methylglutaryl coenzyme A reductase inhibitors on plasma paraoxonase 1 activity in the rat. Pol J Pharmacol. 2002;54(6):661-671.
19. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968;25(1):192-205.
20. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-310.
21. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1994;233:346-357.
22. El-Swefy S, Schaefer EJ, Seman LJ, van DD, Sevanian A, Smith DE, et al. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters. Atherosclerosis. 2000;149(2):277-2786.
23. Ebara T, Hirano T, Mamo JC, Sakamaki R, Furukawa S, Nagano S, et al. Hyperlipidemia in streptozocin-diabetic hamsters as a model for human insulin-deficient diabetes: comparison to streptozocin- diabetic rats. Metabolism. 1994;43(3):299-305.
24. Ebara T, Hirano T, Mamo JC, Sakamaki R, Furukawa S, Nagano S, et al. Hyperlipidemia in streptozocin-diabetic hamsters as a mo-del for human insulin-deficient diabetes: comparison to streptozocin-diabetic rats. Metabolism. 1994;43(3):299-305.
25. Mathe D. Dyslipidemia and diabetes: animal models. Diabete Metab. 1995;21(2):106-111.
26. Bell Jr RH, Hye RJ, Miyai K. Streptozotocin-induced liver tumors in the Syrian hamster. Carcinogenesis. 1984; 5(10):1235-1238.
27. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation. 1997;96(10):3264-3265.
28. Aviram M. Introduction to the serial review on paraoxonases, oxidative stress, and cardiovascular diseases. Free Radic Biol Med. 2004;37(9):1301-1303.
29. Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol. 1995;15(11):1812-1818.
30. Hedrick CC, Hassan K, Hough GP, Yoo JH, Simzar S, Quinto CR, et al. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism. Arterioscler Thromb Vasc Biol. 2000;20(8):1946-1952.
31. Mohan IK, Das UN. Effect of L-arginine-nitric oxide system on chemical-induced diabetes mellitus. Free Radic Biol Med. 1998;25(7):757-765.
32. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89-116.
33. Itoh K, Wakabayashi N, Katoh Y, Ishii T, O'Connor T, Yamamoto M. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells. 2003;8(4):379-391.
34. Dahl EL, Mulcahy RT. Cell-type specific differences in glutamate cysteine ligase transcriptional regulation demonstrate independent subunit control. Toxicol Sci. 2001;61(2):265-272.
35. De Vries HE, Witte M, Hondius D, Rozemuller AJ, Drukarch B, Hoozemans J, et al. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med. 2008;45(10):1375-1383.
36. Aragno M, Tamagno E, Gatto V, Brignardello E, Parola S, Danni O, et al. Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Free Radic Biol Med. 1999;26(11-12):1467-1474.
37. Jain SK. The neonatal erythrocyte and its oxidative susceptibility. Semin Hematol. 1989; 26(4):286-300.
38. Takatori A, Ohta E, Inenaga T, Horiuchi K, Ishii Y, Itagaki S, et al. Protective effects of probucol treatment on pancreatic beta--cell function of SZ-induced diabetic APA hamsters. Exp Anim.2003; 52(4):317-327.
39. Hase M, Babazono T, Karibe S, Kinae N, Iwamoto Y. Renoprotective effects of tea catechin in streptozotocin- induced diabetic rats. Int Urol Nephrol. 2006;38(3-4):693-699.